Overview
Connections
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$3.9M
5 rounds on record
Latest round
$2.1M
Venture round · Jul 2022 · 4 yr ago
Team
11-50
employees, estimated range
Grants
$1.2M
2 grants · CORDIS
Backers
1
BioTools Innovator
The money's age
Long since its last round
51 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 15, 2023 Won a grant $953k · CORDIS Jul 18, 2022 Board appointment Vinod Chachra, Director · SEC Form D Jul 11, 2022 Raised a round Venture round $2.1M · SEC Form D Mar 15, 2021 Won a grant $256k · CORDIS Apr 5, 2019 Raised a round Convertible Note $1.3M · SEC Form D May 24, 2018 Raised a round Convertible Note $500k · SEC Form D 2017 Founded
Funding rounds
RoundDateAmountInvestorsSource
Grant Feb 2023 $953k — CORDIS
Venture round Jul 2022 $2.1M — SEC Form D
Grant Mar 2021 $256k — CORDIS
Convertible Note Apr 2019 $1.3M — SEC Form D
Convertible Note May 2018 $500k — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity CytoRecovery, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Stephen TurnerExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Skin care reinvented. DermaWeave is a breakthrough post-treatment recovery technology from Corryn Biotechnologies Ltd.
Axent Biosciences11-50 employees
Developing next-generation cell therapies utilizing engineered biomaterial technologies.
SiTrationSeed $11.8M · 2 yr ago · Founded 2020
Discover innovative mineral recovery solutions with SiTration, enhancing resource efficiency, reducing waste, and strengthening critical…
RetMap11-50 employees
We design and develop next-generation electroretinography (ERG) products for human and veterinary use.
The NX One family features affordable, flexible cell sorting and dispensing systems designed for single cell separation with gentle…
Build next-generation cell engineering and drug discovery workflows with Portal mechanoporation for broad intracellular delivery across…

Overview

CytoRecovery develops next generation cell sorting & recovery technology.

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
39 portfolio companies: EpiPaws</a> (Copy), Eukarys, Innovator and 36 more

People

Stephen Turner
Executive Officer, Director
Leonard Harris
Director
James Ramey
Director
Vinod Chachra
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Blacksburg United States
HQ
10-50 est. staff

Financials

Total raised
$5.1M
Latest round
Grant
Funding rounds
5
Funding rounds
Round Announced Amount
Grant 2023 $953k Details
Venture - Series Unknown 2022 $2.1M Details
Grant 2021 $256k Details
Convertible Note 2019 $1.3M Details
Convertible Note 2018 $500k Details